Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Squall
    Member
    • Feb 2015
    • 15

    SureSelect Hyb#4 - SDS

    Hi all,

    Could anyone tell me the role of SDS (Hyb#4 buffer I'm assuming) in the hybridisation reaction of SureSelectXT?

    It is causing us some problems and we were wondering how disastrous it would be to titrate it back, or do away with it altogether.

    Thanks!
  • nucacidhunter
    Jafar Jabbari
    • Jan 2013
    • 1250

    #2
    SDS destabilises bonds between probes and library fragments (one of hybridization stringency factors) thereby reduces non-specific hybridization. Omitting it from hyb reaction would result in lower on target capture.

    Comment

    • Squall
      Member
      • Feb 2015
      • 15

      #3
      Thanks nucacidhunter.

      Do you think that it is a linear response? So if we reduced the SDS by 20, 40, 80% etc, that the reduction in on-target would increase accordingly? Or is the SDS present in excess in the reaction?

      Comment

      • nucacidhunter
        Jafar Jabbari
        • Jan 2013
        • 1250

        #4
        I have not seen any formula to calculate the effects. I do not think that it is linear. One way to determine the effect empirically would be to reduce %SDS to the highest that downstream application can tolerate. If off-target levels are high then one can increase hybridisation temperature by 2C to compensate for reduced SDS content. Google searching DNA hybridization kinetics or dynamics should retrieve some related papers.

        Comment

        • melinn21
          Junior Member
          • Jan 2015
          • 1

          #5
          I am also experiencing issues with this. While our data seems to be coming out ok, I'm finding that if I heat and then cool the hyb buffer mix (as the protocol says to do if precipitation forms) I somehow lose volume and never have enough to add to the probes (even with 5% overage). It's very strange. If I measure the volume while its still warm I have the correct volume if I measure while RT it is not enough and the precipitate has essentially returned.

          Comment

          • Squall
            Member
            • Feb 2015
            • 15

            #6
            Thanks hunter for suggestions, will cycle them into the testing plans!

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 07-24-2026, 12:17 PM
            0 responses
            15 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-23-2026, 11:41 AM
            0 responses
            15 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-20-2026, 11:10 AM
            0 responses
            23 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-13-2026, 10:26 AM
            0 responses
            37 views
            0 reactions
            Last Post SEQadmin2  
            Working...